[Asia Economy Reporter Minji Lee] Eutilex announced on the 17th that it has acquired a patent for an anti-human 4-1BB antibody and its related uses.



The company stated, "We will strengthen our technological competitiveness through the commercialization of patented technology and the establishment of a global patent portfolio."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing